Berro, R., Klasse, P. J.
, Jakobsen, M. R., Gorry, P. R., Moore, J. P. & Sanders, R. W. (2012).
V3 determinants of HIV-1 escape from the CCR5 inhibitors Maraviroc and Vicriviroc.
Virology,
427(2), 158-65.
https://doi.org/10.1016/j.virol.2012.02.006
Ishima, Y., Shinagawa, T., Yoneshige, S.
, Kragh-Hansen, U., Ohya, Y., Inomata, Y., Kai, T., Otagiri, M. & Maruyama, T. (2013).
UW solution improved with high anti-apoptotic activity by S-nitrosated human serum albumin.
Nitric Oxide: Biology and Chemistry,
30, 36-42.
Cohen, A., Shainberg, A., Hochhauser, E., Cheporko, Y., Tobar, A., Birk, E., Pinhas, L.
, Leipziger, J. G., Don, J. & Porat, E. (2011).
UTP reduces infarct size and improves mice heart function after myocardial infarct via P2Y2 receptor.
Biochemical Pharmacology,
82(9), 1126-1133.
Reuss, C. F., Jornil, J. R., Vukelic Andersen, L., Hasselstrøm, J. B. & Polak, S. (2018).
Utilizing postmortem drug concentrations in mechanistic modeling and simulation of cardiac effects: a proof of concept study with methadone.
Toxicology Mechanisms and Methods,
28(8), 555-562.
Groennebaek, T., Nielsen, J.
, Jespersen, N. R., Botker, H. E., de Paoli, F. V., Miller, B. F.
& Vissing, K. (2020).
Utilization of biomarkers as predictors of skeletal muscle mitochondrial content after physiological intervention and in clinical settings.
A J P: Endocrinology and Metabolism (Online),
318(6), E886-E889.
https://doi.org/10.1152/ajpendo.00101.2020
Arslanova, A., Shafaattalab, S., Ye, K., Asghari, P., Lin, L., Kim, B. R., Roston, T. M., Hove-Madsen, L., Van Petegem, F., Sanatani, S., Moore, E., Lynn, F., Søndergaard, M.
, Luo, Y., Chen, S. R. W. & Tibbits, G. F. (2021).
Using hiPSC-CMs to Examine Mechanisms of Catecholaminergic Polymorphic Ventricular Tachycardia.
Current Protocols,
1(12), Artikel e320.
https://doi.org/10.1002/cpz1.320
Gaspar, H. A., Gerring, Z., Hübel, C., Middeldorp, C. M., Derks, E. M., Breen, G. & Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium (2019).
Using genetic drug-target networks to develop new drug hypotheses for major depressive disorder.
Translational Psychiatry,
9(1), Artikel 117.
https://doi.org/10.1038/s41398-019-0451-4
Volqvartz, T., Vestergaard, A. L., Aagaard, S. K., Andreasen, M. F., Lesnikova, I.
, Uldbjerg, N., Larsen, A. & Bor, P. (2020).
Use of stimulants, over-the-counter and prescription drugs among Danish pregnant women.
Basic & Clinical Pharmacology & Toxicology,
127(3), 205-210.
https://doi.org/10.1111/bcpt.13396
Larsen, E. R., Damkier, P.
, Pedersen, L. H., Fenger-Gron, J., Mikkelsen, R. L.
, Nielsen, R. E., Linde, V. J., Knudsen, H. E. D.
, Skaarup, L. & Videbech, P. (2015).
Use of psychotropic drugs during pregnancy and breast-feeding.
Acta Psychiatrica Scandinavica,
132(S445), 1-28.
https://doi.org/10.1111/acps.12479
Kjær, D., Horváth-Puhó, E., Christensen, J., Vestergaard, M., Czeizel, AE.
, Sørensen, H. T. & Olsen, J. (2007).
Use of phenytoin, phenobarbital, or diazepam during pregnancy and risk of congenital abnormalities: a case-time-control study.
Pharmacoepidemiology and Drug Safety,
16, 181-8.
Christiansen, G., Ladefoged, S., Hauge, S.
, Birkelund, S. & Andersen, H. (1990).
Use of monoclonal antibodies for detection of gene and antigen variation in Mycoplasma hominis. .
Zbl. Bact. Suppl.,
20, 360-370.
Edemann-Callesen, H., Andersen, H. K., Ussing, A.
, Virring, A., Jennum, P., Debes, N. M.
, Laursen, T., Baandrup, L., Gade, C., Dettmann, J., Holm, J., Krogh, C., Birkefoss, K., Tarp, S. & Händel, M. N. (2023).
Use of melatonin for children and adolescents with chronic insomnia attributable to disorders beyond indication: a systematic review, meta-analysis and clinical recommendation.
EClinicalMedicine,
61, Artikel 102049.
https://doi.org/10.1016/j.eclinm.2023.102049
Hynsjö, L., Granberg, L., Haurum, J.
, Thiel, S. & Larson, G. (1995).
Use of factorial experimental design to delineate the strong calcium- and pH-dependent changes in binding of human surfactant protein-A to neutral glycosphingolipids--a model for studies of protein-carbohydrate interactions.
Analytical Biochemistry,
225(2), 305-14.
https://doi.org/10.1006/abio.1995.1159
Pottegård, A., Lund, L. C., Henriksen, D. P., Folkestad, L.
, Hellfritzsch, M., Hallas, J. & Kristensen, K. B. (2021).
Use of dipeptidyl peptidase-4 inhibitors and risk of splanchnic vein thrombosis: A Danish nationwide new-user active comparator cohort study.
Diabetes, Obesity and Metabolism,
23(2), 648-652.
https://doi.org/10.1111/dom.14253
Volqvartz, T., Vestergaard, A. L., Aagaard, S. K., Andreasen, M. F., Lesnikova, I., Uldbjerg, N., Larsen, A. & Bor, P. (2019).
Use of alternative medicine, ginger and licorice among Danish pregnant women - a prospective cohort study.
BMC Complementary and Alternative Medicine,
19(1), Artikel 5.
https://doi.org/10.1186/s12906-018-2419-y
Birder, L. A.
, Andersson, K. E., Kanai, A. J., Hanna-Mitchell, A. T. & Fry, C. H. (2014).
Urothelial mucosal signaling and the overactive bladder-ICI-RS 2013.
Neurourology and Urodynamics,
33(5), 597-601.
https://doi.org/10.1002/nau.22604
Tokonami, N., Takata, T., Beyeler, J., Ehrbar, I., Yoshifuji, A.
, Christensen, E. I., Loffing, J., Devuyst, O. & Olinger, E. G. (2018).
Uromodulin is expressed in the distal convoluted tubule, where it is critical for regulation of the sodium chloride cotransporter NCC.
Kidney International,
94(4), 701-715. Artikel 94.
https://doi.org/10.1016/j.kint.2018.04.021
Hinrichs, G. R.
, Weyer, K., Friis, U. G., Svenningsen, P., Lund, I. K.
, Nielsen, R., Mollet, G., Antignac, C., Bistrup, C., Jensen, B. L.
& Birn, H. (2019).
Urokinase-type plasminogen activator contributes to amiloride-sensitive sodium retention in nephrotic range glomerular proteinuria in mice.
Acta Physiologica (Online),
227(4), Artikel e13362.
https://doi.org/10.1111/apha.13362
Nykjaer, A., Petersen, C. M., Christensen, E. I., Davidsen, O.
& Gliemann, J. (1990).
Urokinase receptors in human monocytes.
BBA General Subjects,
1052(3), 399-407.
Nykjaer, A., Møller, B. K., Todd, R. F.
, Christensen, T., Andreasen, P., Gliemann, J. & Petersen, C. M. (1994).
Urokinase receptor. An activation antigen in human T lymphocytes.
Journal of Immunology,
152(2), 505-16.
Jensen, P. H., Nykjaer, A., Andreasen, P. A., Lund, L., Astedt, B., Lecander, I.
& Gliemann, J. (1989).
Urokinase binds to a plasminogen activator inhibitor type-2-like molecule in placental microvillous membranes.
BBA General Subjects,
986(1), 135-40.
Nielsen, A. J., Nielsen, M. C., Birn, H., Ivarsen, P., Møller, H. J. & Hviid, C. V. B. (2021).
Urine soluble CD163 (sCD163) as biomarker in glomerulonephritis: stability, reference interval and diagnostic performance.
Clinical Chemistry and Laboratory Medicine,
59(4), 701-709.
https://doi.org/10.1515/cclm-2020-0466
Madsen, M. G., Nørregaard, R., Stødkilde-Jørgensen, L., Christensen, J. H., Jørgensen, T. M. & Frøkiær, J. (2012).
Urine and kidney cytokine profiles in experimental unilateral acute and chronic hydronephrosis.
Scandinavian Journal of Urology and Nephrology,
46(2), 91-96.
https://doi.org/10.3109/00365599.2011.637958
Nørregaard, R., Jensen, B. L., Topcu, S. O.
, Wang, G., Schweer, H.
, Nielsen, S. & Frøkiaer, J. (2010).
Urinary tract obstruction induces transient accumulation of COX-2-derived prostanoids in kidney tissue.
American Journal of Physiology: Regulatory, Integrative and Comparative Physiology,
298(4), R1017-25.
https://doi.org/10.1152/ajpregu.00336.2009
Wilmer, M. J.
, Christensen, E. I., van den Heuvel, L. P., Monnens, L. A. & Levtchenko, E. A. (2008).
Urinary protein excretion pattern and renal expression of megalin and cubilin in nephropathic cystinosis.
American Journal of Kidney Diseases,
51, 893-903.
Rodionova, E. A., Kuznetsova, A. A., Shakhmatova, E. I., Prutskova, N.
, Nielsen, S., Holtbäck, U., Natochin, Y. & Zelenina, M. (2006).
Urinary Aquaporin-2 in Children with Acute Pyelonephritis.
Pediatric Nephrology,
21, 361-367.
Wang, G., Li, C., Kim, SW.
, Ring, T., Wen, J.
, Djurhuus, J. C., Wang, W.
, Nielsen, S. & Frøkiær, J. (2008).
Ureter obstruction alters expression of renal acid-base transport proteins in rat kidney. American Journal of Physiology: Renal Physiology,
295(2), 497-506.
Mutsaers, H. A. M., van den Heuvel, L. P., Ringens, L. H. J., Dankers, A. C. A., Russel, F. G. M., Wetzels, J. F. M., Hoenderop, J. G. & Masereeuw, R. (2011).
Uremic toxins inhibit transport by breast cancer resistance protein and multidrug resistance protein 4 at clinically relevant concentrations.
PLOS ONE,
6(4), Artikel e18438.
https://doi.org/10.1371/journal.pone.0018438